Rezultati

eNauka >  Results >  Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
Title: Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
Authors Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijusković, Željko P.  ; ...; (broj, koautora 20)
Issue Date: 2024
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 e1569-8041 Annals of Oncology Search Idenfier
Publisher: London : Elsevier
Type: Conference Paper
Collation: vol. 35 br. Article Number LBA45 str. 1235-1236
DOI: 10.1016/j.annonc.2024.08.2286
WoS-ID: 001326612903053
URI: https://enauka.gov.rs/handle/123456789/974895
URL: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2824%2903866-3
Project: F. Hoffmann-La Roche Ltd.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

3
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.